Several studies support predictions that CSP resynchronization therapy will ultimately emerge as equal or superior to biventricular pacing at improving LVEF and clinical outcomes in heart failure
Ablation has hogged the electrophysiology spotlight recently, but three presentations at the 2022 Heart Rhythm Society meeting put cardiac pacing on the comeback trail.